ON
← Nazaj na pregled
Antnio Marques je bil diagnosticiran s pljučnim rakom in je umrl brez zraka zaradi kemoterapije.
PT🏛️ Politika7. 5. 2019

Antnio Marques je bil diagnosticiran s pljučnim rakom in je umrl brez zraka zaradi kemoterapije.

The article reports on the case of António Marques, a 61-year-old man diagnosed with lung cancer in January 2019 who died without beginning chemotherapy. He had to wait seven times longer than recommended for a critical test at the Hospital de Portimão, which delayed his treatment. His wife feels this delay prevented the family from saying goodbye to him in a dignified manner. The article highlights that this is not an isolated incident, citing multiple cases where patients faced similar challenges due to financial constraints or systemic issues within the healthcare system.

1 poročil

Correio da Manhã logoCorreio da ManhãNeodvisenLevo7. 5. 2019
Antnio Marques je bil diagnosticiran s pljučnim rakom in je umrl brez zraka zaradi kemoterapije.

The article reports on the case of António Marques, a 61-year-old man diagnosed with lung cancer in January 2019 who died without beginning chemotherapy. He had to wait seven times longer than recommended for a critical test at the Hospital de Portimão, which delayed his treatment. His wife feels this delay prevented the family from saying goodbye to him in a dignified manner. The article highlights that this is not an isolated incident, citing multiple cases where patients faced similar challenges due to financial constraints or systemic issues within the healthcare system.

Ocena pristranskosti (Levo): The article frames the issue as a systemic problem within the healthcare system, emphasizing delays caused by financial constraints and highlighting the human cost of such failures. It uses emotionally charged language ('pesadelo'—nightmare, 'digna'—dignified) and presents the situation as a failure

Ohranimo novice poštene.

ObjectiveNews financirajo bralci in je brez oglasov – pristranskost vam pokažemo, ne skrijemo. Podprite neodvisno novinarstvo za 5 €/mesec.

Postani podpornik

Povezane zgodbe